Whitespace announces another collaboration agreement, this time it's with Sideways 6!
2020 saw Whitespace partner with one of the worlds largest tech companies and leading pharmaceutical company, Pfizer.
The Artificial Intelligence (AI) in Histopathology Tech Innovation Challenge invited fast-growth technology start-ups and SMEs to help develop an AI solution that can streamline processes, identify specimens and effectively assist histopathologists in reviewing and reporting individual cases.
Additionally, the technology could also be used for future quality assessments of histopathology services. The winning startup would receive the opportunity to design a proof of concept for NHS engagement in 2021.
Hamish continues, “By combining IBM’s support for SMEs and their technology expertise with Whitespace’s knowledge of innovation engineering, we are well-positioned to take on this exciting challenge. Our goal is to find high potential technology companies with relevant experience in digital pathology and histology, or that have a background in developing ML Vision technology for healthcare and related industries, that want to work with pathologists to help address challenges in the UK. The successful applicants will be given the opportunity to showcase their product to the NHS and associated data hubs.”
Deborah Threadgold, Vice President Next-Generation Ecosystem, EMEA at IBM, adds: “IBM is passionate about supporting collaboration amongst technology providers. We have seen time and again that there is no challenge too great if we combine the right capabilities and technology from partners across the ecosystem. We are proud to be working with Whitespace and Pfizer on this Tech Innovation Challenge and look forward to a new breed of advancements in AI in the UK Healthcare industry from those who take up the challenge.”
Andrew Webber, Chief Marketing Officer at Whitespace, concludes: “As is becoming increasingly the case in this day and age, ambitious and high growth technology companies have a crucial role to play in collaborating with corporates to support technological innovation. It is extremely encouraging that Pfizer and IBM share this vision as global leaders in healthcare and technology.”
In December, 5 chosen startups presented their solutions to an online audience which included the NHS. Due to Covid delays, the winning startup is yet to be chosen, so watch this space for our next update!
PP-INP-GBR-0144 – October 2020